型号:
产品价格:电议      采购度:1613      原产地:美洲
发布时间:2021/7/28 17:36:32 所属地区:上海 上海市
简要描述:
c-Kit-IN-3 (D-tartrate) (Compound 18) 是一种有效的?c-KIT kinase?激酶抑制剂,对?BaF3-tel-c-KIT?(IC50?为 4 nM) 和广泛的耐药性突变体 (对?BaF3-tel-c-KIT-T670I?的IC50为 8 nM),具有很高的生物利用度。
标签:dtartrate
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
MCE 站:c-Kit-IN-3 D-tartrate
产品活性:c-Kit-IN-3 (D-tartrate) (Compound 18) 是一种有效的?c-KIT kinase?激酶抑制剂,对?BaF3-tel-c-KIT?(IC50?为 4 nM) 和广泛的耐药性突变体 (对?BaF3-tel-c-KIT-T670I?的IC50为 8 nM),具有很高的生物利用度。
研究领域:Protein Tyrosine Kinase/RTK
作用靶点:c-Kit
In Vitro: c-Kit-IN-3 (D-tartrate) (Compound 18; 0.006 μM-1.37 μM) potently inhibits the growth of c-KIT-dependent GIST cancer cells, such as GIST-T1 (GI50: 0.006 μM); GIST-882 (GI50: 0.013 μM); GIST-T1-T670I (GI50?: 0.011 μM); GIST-5R (GI50: 0.073 μM); GIST-48B (GI50: 1.37 μM), respectively.c-Kit-IN-3 (D-tartrate) (Compound 18; 0.01-1 μM; 24 hours; GIST-T1, GIST-T1-T670I, and GIST-5R cells) treatment induces dose-dependent cell apoptotic death (by examining the cleaved PARP and cleaved caspase 3).c-Kit-IN-3 (D-tartrate) (Compound 18; 0.01-1 μM; 24 hours; GIST-T1, GIST-T1-T670I, and GIST-5R cells) treatment arrests the cell cycle into the G0/G1 phase in all of these three cell lines.c-Kit-IN-3 (D-tartrate) (Compound 18; 0.1-10 μM; 6 days; primary GIST patient cells) exhibits dose-dependent antiproliferative effects.c-Kit-IN-3 (D-tartrate) (Compound 18; 0-1 μM; 24 hours) blocks the autophosphorylation of c-KIT pY703, pY719, and pY823 in GIST-T1, GIST-T1-T670I, and GIST-5R, respectively, cells at a concentration of 30 nM and inhibits the downstream signaling mediators pAKT (T308/S473), pS6 (S235/236), and pERK (T202/204).c-Kit-IN-3 (D-tartrate) (Compound 18; 0-1 μM; 2 hours) induces dose-dependent cell apoptotic death (by examining the cleaved PARP and cleaved caspase 3) and arrest the cell cycle into the G0/G1 phase in all of these three cell lines.
In Vivo: c-Kit-IN-3 (D-tartrate) (Compound 18; 40-100 mg/kg; oral gavage; daily; for 11 days; for 4 weeks; female BALB/C-nu mice) treatment dose dependently inhibits the BaF3-tel-c-KIT-T670I tumor progression and exhibited almost 100% TGI (tumor growth inhibition) at a dosage of 100 mg/kg/day. And do not affect the animal weights.
相关产品:Imatinib | AST 487 | Ki20227 | Motesanib | SU14813 | ISCK03 | PLX647 | Tyrphostin AG1296 | CHMFL-ABL/KIT-155 | Imatinib D4 | Imatinib D8 | Multi-kinase inhibitor 1 | PD180970
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:16:51
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品